Midori Yokoyama

Finance

Profile

Mrs Midori Yokoyama is responsible for the portfolio's US companies.
She has strong experience in business development and strategic planning of portfolio companies in the US, Europe and Asia.
Previously, she was involved in technical assessment of in-licensing opportunities at TAP Pharmaceutical Products (Takeda-Abbott JV, US).
Prior to TAP, she worked for a start-up biotechnology company, formerly known as Trophix Pharmaceuticals (New Jersey, US) where she held positions in business development and R&D.
Mrs. Yokoyama holds a PhD in neurobiology from Cornell University Medical College and an MBA from Northwestern University Kellogg School of Management.

Former positions of Midori Yokoyama

Companies	Position	End
Société Générale Asset Mgmt Alternative Invt (Private Equity) Société Générale Asset Mgmt Alternative Invt (Private Equity) Investment ManagersFinance Societé Générale Asset Management Alternative Investment/Private Equity (SGAM AI/PE) is the banking group's European asset management center for Private Equity. They are located in Paris-La Défense. SGAM AI/PE is a division of the Société Générale Asset Management, established in 2003, which is a subsidiary of the bank's Global Investment Management and Services division. The ultimate parent firm is the French financial institution Société Générale (PK: SCGLY), established in 1864. Nationalized at different intervals throughout their history, the bank is in the private sector since 1997. SGAM AI/PE is composed of three units: venture capital, expansion capital and buyout, and fund of funds. In addition to their Paris office, they are also present in London, Milan, Munich, Warsaw, Bucharest and Casablanca.	Private Equity Investor	15/02/2010

See the detail of Midori Yokoyama's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies